EU Antitrust Regulators Unlikely To Seek Feedback From Rivals, Users To EEX's Remedies For Nasdaq Deal; Regulators Likely See Remedies As Insufficient, Expected To Open Investigation Into Deal; EEX Could Stave Off Investigation If It Offers More Remedies In Coming Days, Sources Say
Portfolio Pulse from Benzinga Newsdesk
EU antitrust regulators are unlikely to seek feedback from rivals and users regarding EEX's proposed remedies for its deal with Nasdaq. The regulators likely view the remedies as insufficient and are expected to open an investigation into the deal. EEX could potentially avoid the investigation by offering more remedies in the coming days, according to sources.
June 03, 2024 | 3:25 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
EU antitrust regulators are likely to open an investigation into EEX's deal with Nasdaq, viewing the current remedies as insufficient. Nasdaq's stock could face short-term pressure due to regulatory uncertainties.
The potential investigation by EU antitrust regulators introduces regulatory uncertainty, which is typically negative for stock prices. Nasdaq's involvement in the deal means its stock could face short-term pressure until the situation is resolved.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100